Hubei Guangji Pharmaceutical Co., Ltd. (000952.SZ)
CNY 6.24
(-0.79%)
CNY 6.24
(-0.79%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 935.85 Million CNY | 54.59% |
| 2022 | 605.38 Million CNY | 62.38% |
| 2021 | 372.82 Million CNY | 22.71% |
| 2020 | 303.83 Million CNY | -49.06% |
| 2019 | 596.5 Million CNY | 8.08% |
| 2018 | 551.92 Million CNY | 3.87% |
| 2017 | 531.37 Million CNY | 4.82% |
| 2016 | 506.92 Million CNY | -1.71% |
| 2015 | 515.73 Million CNY | 1.93% |
| 2014 | 505.99 Million CNY | 79.6% |
| 2013 | 281.73 Million CNY | -25.09% |
| 2012 | 376.11 Million CNY | 2.33% |
| 2011 | 367.54 Million CNY | 11.72% |
| 2010 | 328.97 Million CNY | 18.47% |
| 2009 | 277.68 Million CNY | 242.81% |
| 2008 | 81 Million CNY | 3.85% |
| 2007 | 78 Million CNY | -63.29% |
| 2006 | 212.5 Million CNY | -19.51% |
| 2005 | 264 Million CNY | -9.39% |
| 2004 | 291.37 Million CNY | 16.01% |
| 2003 | 251.17 Million CNY | 11.55% |
| 2002 | 225.17 Million CNY | 18.64% |
| 2001 | 189.8 Million CNY | 65.87% |
| 2000 | 114.43 Million CNY | -10.19% |
| 1999 | 127.41 Million CNY | -3.85% |
| 1998 | 132.52 Million CNY | 32.57% |
| 1997 | 99.96 Million CNY | 20.56% |
| 1996 | 82.91 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 997.37 Million CNY | 6.57% |
| 2024 Q2 | 1.09 Billion CNY | 9.95% |
| 2024 Q3 | 793.08 Million CNY | -29.11% |
| 2023 Q2 | 1.03 Billion CNY | 56.4% |
| 2023 Q3 | 963.34 Million CNY | -6.85% |
| 2023 Q1 | 661.26 Million CNY | 9.23% |
| 2023 FY | 935.85 Million CNY | 54.59% |
| 2023 Q4 | 935.85 Million CNY | -2.85% |
| 2022 FY | 605.38 Million CNY | 62.38% |
| 2022 Q4 | 605.38 Million CNY | 14.17% |
| 2022 Q3 | 530.27 Million CNY | 32.48% |
| 2022 Q2 | 400.26 Million CNY | -16.61% |
| 2022 Q1 | 479.99 Million CNY | 28.75% |
| 2021 Q3 | 408.74 Million CNY | -19.01% |
| 2021 Q4 | 372.82 Million CNY | -8.79% |
| 2021 Q1 | 280.05 Million CNY | -7.83% |
| 2021 Q2 | 504.65 Million CNY | 80.2% |
| 2021 FY | 372.82 Million CNY | 22.71% |
| 2020 Q2 | 507.04 Million CNY | -11.66% |
| 2020 Q1 | 573.93 Million CNY | -3.78% |
| 2020 Q3 | 424.43 Million CNY | -16.29% |
| 2020 Q4 | 303.83 Million CNY | -28.41% |
| 2020 FY | 303.83 Million CNY | -49.06% |
| 2019 Q2 | 686.32 Million CNY | 3.39% |
| 2019 Q1 | 663.83 Million CNY | 20.28% |
| 2019 FY | 596.5 Million CNY | 8.08% |
| 2019 Q3 | 572.95 Million CNY | -16.52% |
| 2019 Q4 | 596.5 Million CNY | 4.11% |
| 2018 Q1 | 531.6 Million CNY | 0.04% |
| 2018 FY | 551.92 Million CNY | 3.87% |
| 2018 Q4 | 551.92 Million CNY | 17.69% |
| 2018 Q3 | 468.97 Million CNY | -14.75% |
| 2018 Q2 | 550.11 Million CNY | 3.48% |
| 2017 Q2 | 528.55 Million CNY | 4.84% |
| 2017 FY | 531.37 Million CNY | 4.82% |
| 2017 Q1 | 504.14 Million CNY | -0.55% |
| 2017 Q3 | 577.81 Million CNY | 9.32% |
| 2017 Q4 | 531.37 Million CNY | -8.04% |
| 2016 Q2 | 510.19 Million CNY | 1.81% |
| 2016 FY | 506.92 Million CNY | -1.71% |
| 2016 Q4 | 506.92 Million CNY | 0.49% |
| 2016 Q3 | 504.45 Million CNY | -1.12% |
| 2016 Q1 | 501.13 Million CNY | -2.83% |
| 2015 Q2 | 443.51 Million CNY | -13.79% |
| 2015 FY | 515.73 Million CNY | 1.93% |
| 2015 Q4 | 515.73 Million CNY | 27.03% |
| 2015 Q3 | 406 Million CNY | -8.46% |
| 2015 Q1 | 514.43 Million CNY | 1.67% |
| 2014 Q2 | 232.74 Million CNY | 41.4% |
| 2014 Q4 | 505.99 Million CNY | 136.61% |
| 2014 FY | 505.99 Million CNY | 79.6% |
| 2014 Q1 | 164.6 Million CNY | -41.58% |
| 2014 Q3 | 213.85 Million CNY | -8.12% |
| 2013 FY | 281.73 Million CNY | -25.09% |
| 2013 Q3 | 377.08 Million CNY | 2.84% |
| 2013 Q2 | 366.65 Million CNY | -0.14% |
| 2013 Q1 | 367.16 Million CNY | -2.38% |
| 2013 Q4 | 281.73 Million CNY | -25.29% |
| 2012 Q4 | 376.11 Million CNY | -4.52% |
| 2012 Q3 | 393.92 Million CNY | 0.59% |
| 2012 Q1 | 388.52 Million CNY | 5.71% |
| 2012 FY | 376.11 Million CNY | 2.33% |
| 2012 Q2 | 391.61 Million CNY | 0.8% |
| 2011 FY | 367.54 Million CNY | 11.72% |
| 2011 Q2 | 284.6 Million CNY | -12.65% |
| 2011 Q4 | 367.54 Million CNY | 7.15% |
| 2011 Q1 | 325.82 Million CNY | -0.96% |
| 2011 Q3 | 343 Million CNY | 20.52% |
| 2010 Q2 | 350.52 Million CNY | 38.7% |
| 2010 FY | 328.97 Million CNY | 18.47% |
| 2010 Q3 | 357.72 Million CNY | 2.05% |
| 2010 Q1 | 252.72 Million CNY | -8.99% |
| 2010 Q4 | 328.97 Million CNY | -8.03% |
| 2009 Q4 | 277.68 Million CNY | -7.03% |
| 2009 Q1 | 161 Million CNY | 98.77% |
| 2009 Q2 | 308.68 Million CNY | 91.73% |
| 2009 Q3 | 298.68 Million CNY | -3.24% |
| 2009 FY | 277.68 Million CNY | 242.81% |
| 2008 Q3 | 84 Million CNY | 5.0% |
| 2008 Q4 | 81 Million CNY | -3.57% |
| 2008 Q1 | 78 Million CNY | 0.0% |
| 2008 FY | 81 Million CNY | 3.85% |
| 2008 Q2 | 80 Million CNY | 2.56% |
| 2007 Q3 | 110.5 Million CNY | -37.22% |
| 2007 Q4 | 78 Million CNY | -29.41% |
| 2007 FY | 78 Million CNY | -63.29% |
| 2007 Q1 | 227.5 Million CNY | 7.06% |
| 2007 Q2 | 176 Million CNY | -22.64% |
| 2006 Q4 | 212.5 Million CNY | -1.16% |
| 2006 Q2 | 225 Million CNY | -11.94% |
| 2006 Q1 | 255.5 Million CNY | -3.22% |
| 2006 FY | 212.5 Million CNY | -19.51% |
| 2006 Q3 | 215 Million CNY | -4.44% |
| 2005 Q4 | 264 Million CNY | -8.07% |
| 2005 Q3 | 287.17 Million CNY | -2.21% |
| 2005 Q2 | 293.67 Million CNY | -2.17% |
| 2005 Q1 | 300.17 Million CNY | 3.02% |
| 2005 FY | 264 Million CNY | -9.39% |
| 2004 Q2 | 296.17 Million CNY | 13.4% |
| 2004 FY | 291.37 Million CNY | 16.01% |
| 2004 Q1 | 261.17 Million CNY | 3.98% |
| 2004 Q3 | 277.17 Million CNY | -6.42% |
| 2004 Q4 | 291.37 Million CNY | 5.12% |
| 2003 Q2 | 224.17 Million CNY | -1.97% |
| 2003 Q3 | 229.17 Million CNY | 2.23% |
| 2003 Q1 | 228.67 Million CNY | 1.55% |
| 2003 FY | 251.17 Million CNY | 11.55% |
| 2003 Q4 | 251.17 Million CNY | 9.6% |
| 2002 FY | 225.17 Million CNY | 18.64% |
| 2002 Q2 | 179.6 Million CNY | 0.0% |
| 2002 Q1 | - CNY | -100.0% |
| 2002 Q3 | 191.6 Million CNY | 6.68% |
| 2002 Q4 | 225.17 Million CNY | 17.52% |
| 2001 Q2 | 164.13 Million CNY | 0.0% |
| 2001 Q4 | 189.8 Million CNY | 0.0% |
| 2001 FY | 189.8 Million CNY | 65.87% |
| 2000 Q2 | 108.43 Million CNY | 0.0% |
| 2000 FY | 114.43 Million CNY | -10.19% |
| 2000 Q4 | 114.43 Million CNY | 0.0% |
| 1999 Q4 | 127.41 Million CNY | 0.0% |
| 1999 Q2 | 138.05 Million CNY | 0.0% |
| 1999 FY | 127.41 Million CNY | -3.85% |
| 1998 FY | 132.52 Million CNY | 32.57% |
| 1997 FY | 99.96 Million CNY | 20.56% |
| 1996 FY | 82.91 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 2.54 Billion CNY | 63.199% |
| Zhejiang Zhenyuan Share Co., Ltd. | 138.12 Million CNY | -577.521% |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | 593.88 Million CNY | -57.584% |
| Yifan Pharmaceutical Co., Ltd. | 1.99 Billion CNY | 53.094% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | 4.36 Million CNY | -21336.593% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 7.55 Billion CNY | 87.614% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | 273.99 Million CNY | -241.556% |
| Boai NKY Medical Holdings Ltd. | 60.4 Million CNY | -1449.226% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | 62.44 Million CNY | -1398.741% |